GlobeNewswire Inc.··Mesoblast LimitedMesoblast Plans First R&D Day to Showcase Pipeline, New Cell Therapy Tech
Mesoblast Limited will host inaugural R&D Day April 8, 2026 in NYC, featuring Ryoncil commercialization updates and new cellular medicine technology.
MESORyoncil®cellular medicines